These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29943329)

  • 1. [Generic antiretroviral drugs and their potential for cost reduction].
    Stoll M
    MMW Fortschr Med; 2018 Jun; 160(Suppl 2):37-39. PubMed ID: 29943329
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for generic antiretroviral drugs in the United States?
    Wormser GP; Lappas T
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of generic antiretroviral therapy.
    Hirnschall G; de Joncheere C
    Ann Intern Med; 2013 May; 158(10):776. PubMed ID: 23689769
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic drugs battle moves from South Africa to Kenya.
    Siringi S
    Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of generic antiretroviral therapy--in response.
    Walensky RP; Paltiel AD; Schackman BR
    Ann Intern Med; 2013 May; 158(10):776-7. PubMed ID: 23689770
    [No Abstract]   [Full Text] [Related]  

  • 8. Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction.
    Rwagitinywa J; Sommet A; Palmaro A; Montastruc JL; Lapeyre-Mestre M
    Health Policy; 2018 Mar; 122(3):237-242. PubMed ID: 29398158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Declining costs].
    Neumaier J
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
    [No Abstract]   [Full Text] [Related]  

  • 10. Generic antiretroviral drugs--will they be the answer to HIV in the developing world?
    Kumarasamy N
    Lancet; 2004 Jul 3-9; 364(9428):3-4. PubMed ID: 15234833
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of generic HIV drugs in Rhode Island.
    Lee JY; Reece R; Montague B; Rana A; Alexander-Scott N; Flanigan T
    R I Med J (2013); 2013 Sep; 96(9):30-3. PubMed ID: 24015398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 13. New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy).
    Restelli U; Scolari F; Bonfanti P; Croce D; Rizzardini G
    BMC Infect Dis; 2015 Aug; 15():323. PubMed ID: 26259842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing the affordability gap for drugs in low-income countries.
    Steinbrook R
    N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?
.
    Cattaneo D; Andreoni M; Carosi G; Cauda R; Lazzarin A; Rizzardini G
    Int J Clin Pharmacol Ther; 2017 May; 55(5):381-393. PubMed ID: 28211784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic antiretroviral drugs are a credible and cheaper alternative to brands.
    BMJ; 2013 Jan; 346():f250. PubMed ID: 23325870
    [No Abstract]   [Full Text] [Related]  

  • 17. Paying for life. The issues behind drug pricing.
    Huff B
    GMHC Treat Issues; 2003 Nov; 17(11):1-7. PubMed ID: 14717105
    [No Abstract]   [Full Text] [Related]  

  • 18. Legal, ethical, and economic implications of breaking down once-daily fixed-dose antiretroviral combinations into their single components for cost reduction.
    Ramiro MA; Llibre JM
    Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):598-602. PubMed ID: 24139337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The patent legislation in India fails the HIV/AIDS work].
    Holen Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
    Venkatesh KK; Mayer KH; Carpenter CC
    Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.